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Background: Many malarious countries plan to introduce artemisinin combination therapy (ACT) at community
level using community health workers (CHWs) for treatment of uncomplicated malaria. Use of ACT with reliance on
presumptive diagnosis may lead to excessive use, increased costs and rise of drug resistance. Use of rapid
diagnostic tests (RDTs) could address these challenges but only if the communities will accept their use by CHWs.
This study assessed community acceptability of the use of RDTs by Ugandan CHWs, locally referred to as
community medicine distributors (CMDs).
Methods: The study was conducted in Iganga district using 10 focus group discussions (FGDs) with CMDs and
caregivers of children under five years, and 10 key informant interviews (KIIs) with health workers and community
leaders. Pre-designed FGD and KII guides were used to collect data. Manifest content analysis was used to explore
issues of trust and confidence in CMDs, stigma associated with drawing blood from children, community
willingness for CMDs to use RDTs, and challenges anticipated to be faced by the CMDs.
Results: CMDs are trusted by their communities because of their commitment to voluntary service, access, and the
perceived effectiveness of anti-malarial drugs they provide. Some community members expressed fear that the
blood collected could be used for HIV testing, the procedure could infect children with HIV, and the blood
samples could be used for witchcraft. Education level of CMDs is important in their acceptability by the
community, who welcome the use of RDTs given that the CMDs are trained and supported. Anticipated challenges
for CMDs included transport for patient follow-up and picking supplies, adults demanding to be tested, and
caregivers insisting their children be treated instead of being referred.
Conclusion: Use of RDTs by CMDs is likely to be acceptable by community members given that CMDs are
properly trained, and receive regular technical supervision and logistical support. A well-designed behaviour
change communication strategy is needed to address the anticipated programmatic challenges as well as
community fears and stigma about drawing blood. Level of formal education may have to be a criterion for CMD
selection into programmes deploying RDTs.
Background
Globally 3.2 billion people remain at risk of malaria and
nearly one million malaria deaths occur each year,
mostly in children under five years of age in sub-
Saharan Africa [1]. Besides neonatal-related causes,
malaria is the second leading cause of morbidity and
mortality in Africa, and accounts for 21-26% of all
under-five mortality in Uganda [2,3]. Many of these
deaths occur at home due to poor access to health care,
inappropriate or delayed care seeking and inadequate
quality of health services [2,4]. Based on the current
body of evidence, community health workers (CHWs)
c a np l a ya ni m p o r t a n tr o l ei ni n c r e a s i n gc o v e r a g eo f
essential interventions for child survival [5]. One such
strategy recommended by WHO and UNICEF is Home
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to be effective in reducing malaria mortality and mor-
bidity in under-five children in a number of malaria
endemic countries [6-8].
Since 2002, Uganda has adopted and implemented
HMM at scale, locally referred to as Home Based Man-
agement of Fever (HBMF) strategy [9-11]. Under
HBMF, community medicine distributors (CMDs) pro-
vided unit-dosed prepackaged Homapak™ (chloroquine
and sulphadoxine/pyrimethamine - CQ + SP) presump-
tively to children that presented with, or had a history
of fever [9]. More than 45% of first care contact for
under-five children with fever was obtained through
HBMF in program areas [12], and Kilian et al [13]
found that caregivers of children had high acceptability
towards Homapak™.
Due to increase in resistance to CQ and SP, in 2006
the National Malaria Control Programme (NMCP)
made a policy change to cost-free artemisinin-based
combination therapy (ACT) at all levels of the health
system - including community level. Coartem®, the ACT
that is in use Uganda is composed of a fixed combina-
tion of 20 mg of artemether and 120 mg of lumefantrine
and is supplied in prepacked weight- and age-specific
forms. There are concerns that the introduction of such
a highly efficacious but expensive new treatment at
community level, with reliance on presumptive diagnosis
alone, may lead to excessive use, increased costs and
risk of development of resistance [14,15].
The encouraging decline in malaria prevalence that
has been observed in several African countries where
integrated malaria control strategies have been imple-
mented on a large scale [16-20] may also amplify the
risk of misdiagnosis of fever episodes in absence of
malaria diagnostic tools [21]. With policies that recom-
mend presumptive treatment of fever, health workers
and caretakers are less likely to look for other causes of
fever, leading to delay in appropriate treatment and
higher case fatality rates among non-malaria fevers than
in malaria fevers [22]. There is limited evidence that
shows change in malaria prevalence in the recent past
in Uganda [23].
Given that rapid diagnostic tests (RDTs) are now
available with sensitivities comparable to routine micro-
scopy in detecting malaria [24-27] these tests are now
increasingly being seen as an alternative to improve
diagnosis and quality of care of febrile children in
malarious areas [10,28]. RDTs are now being rolled out
in many countries to all tiers of the formal health care
system to guide malaria treatment decisions in routine
care [29]. The potential role of RDTs in HMM is still
highly debated; a facility based study in Tanzania found
some caregivers with reservations about RDTs for
malaria, thinking they were HIV test kits [30]. Studies
from sub-Saharan Africa [31-33] document community
stigma about drawing blood that may impede accept-
ability of RDTs. In addition, English et al [34] argue
that there is inadequate evidence to support abandoning
presumptive treatment and that African health systems
have yet to demonstrate the capacity to support a shift
toward laboratory-confirmed diagnosis rather than pre-
sumptive treatment of malaria in children under five.
Some of these concerns include the implications of not
providing treatment to childern with false-negative test
results. Finally, diffusion of innovations in the health
system depend on individuals’ perceptions of the inno-
vation, characteristics of the individual who may adopt
the change, and contextual factors within the commu-
nity [35]. It is still unclear what role RDTs will play in a
situation where HBMF recommendations are blended
with local and biomedical knowledge, and little is
known about whether the community will accept the
use of RDTs in the hands of CMDs with low education
level and no formal health care background. The aim of
this study was, therefore, to explore community accept-
ability of the use of RDTs for malaria diagnosis by
CMDs within the context of community case manage-
ment of fever in children under five in Uganda.
Methods
Study area
The study was conducted in the rural Ugandan district
of Iganga as part of a larger study on the feasibility of
deploying RDTs at community level in Uganda (Clinical
Trials.gov Identifier NCT00720811). Uganda has an esti-
mated population of 34 million inhabitants of whom
about 80% live in rural areas. The economy is predomi-
nantly agricultural with the majority of the population
dependent on subsistence farming.
Iganga District is located in South Eastern Uganda,
approximately 112 km from Kampala, the capital city of
Uganda. Iganga district is served by a 200-bed capacity
hospital, and 81 health centres at county, sub-county
and parish level. The main local language spoken in the
district is Lusoga. Iganga has high transmission rates
(holoendemic) for malaria [36]. HBMF was started in
Iganga district in 2003 with district-wide 3-day training
of CMDs in use of Homapak®. All the CMDs were
retrained over 3 days in using Coartem® in 2006, but
due to inadequate stocks of ACT at national level the
medicines were limited to facility-based deployment and
were not deployed through CMDs during this study per-
iod. The study was conducted in August 2008 in the
sub-county of Namungalwe, which has a total popula-
tion of 32,911 in seven parishes and 19 villages. There
are a total of 48 CMDs in the sub-county, majority of
who are female and have attained some secondary
school education. The sub-county of Namungalwe was
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will introduce the use of RDTs by CMDs.
Data collection
A qualitative research approach using Focus Group Dis-
cussions (FGDs) and Key Informant (KI) interviews was
deemed appropriate for the study aim. Ten FGDs with
6-10 participants in each group were conducted with
caregivers of under-five children and CMDs (Table 1).
Whereas most fevers are managed by mothers, FGDs
were also conducted separately with fathers, as they play
a significant role in the health care seeking of sick chil-
dren, especially when costs are incurred [37].
FGD participants were mobilized by the community
leaders and purposively selected if they had ever cared
for a child with fever. FGDs were conducted in different
parishes, and took place in one of the homes of the par-
ticipants to provide for privacy. Pre-designed interview
guides were piloted and used to collect information on
trust and confidence in CMDs, community willingness
and acceptability of CMDs to use RDTs, anticipated
challenges that CMDs could be faced with using RDTs,
and stigma associated with taking blood from children
in the community. Both the interviewer and the note
taker were social scientists, spoke both English and the
vernacular fluently and were experienced in conducting
FGDs. The first FGDs were attended by two of the
research team members who reviewed the notes after-
wards. They also discussed with the interviewer and the
note taker their experiences of the emerging issues and
whether questions were being understood.
Key informant interviews were conducted with health
workers and different community leaders (Table 1) to
capture their experiences of CMD management of sick
children, their perceptions of CMDs’ abilities in using
RDTs as part of the treatment of children with fever,
anticipated challenges that CMDs could face with using
RDTs and stigma associated with taking blood from
children in the community. The research assistants were
trained by the investigators on how to use the KI inter-
view guide.
All the FGDs and KI interviews were conducted in the
local language, transcribed and later translated into Eng-
lish by the interviewers. The participants had never seen
nor had an RDT used on them, and during interviews
the RDT test was described to the interviewees.
Data analysis
Manifest content analysis [38] was used to categorize
k e yi s s u e so u to ft h ed a t a .T h eu n i to fa n a l y s i sw a st h e
t r a n s c r i p t sf r o mF G D sa n dK I I s .T h ea u t h o r s( D M ,J T ,
JK, BM, GO and KK) read through the data, identified
different issues and debated them, and eventually devel-
oped codes. A second review of the material was done
that generated more codes, which were discussed and
agreed upon. These codes were merged into categories
and then into themes reflecting the study objectives and
other emerging issues.
Ethical clearance
E t h i c a la p p r o v a lf o rt h es t u d yw a so b t a i n e df r o mt h e
WHO Ethical Review Committee, the Makerere Univer-
sity School of Public Health Institutional Review Board,
and the Uganda National Council for Science and Tech-
nology. Presentations to the district health team for
Iganga district, as well as to the local area authorities at
t h es u b - c o u n t yw e r em a d ea n dp e r m i s s i o no b t a i n e d
from them to conduct the study. Individual written
(signed or thumb print) informed consent was obtained
from each of the study participants for both key infor-
mant interviews and focus group discussions.
Results
There were four key findings of the study: (1) CMDs are
trusted by their communities because of their commit-
ment to voluntarism, accessibility, and the perceived
effectiveness of the anti-malarial drugs used, and their
activities have led to a perception of reduced workload
among health workers in health facilities; (2) community
members, health workers and CMDs welcomed the use
of RDTs by CMDs provided they have sufficient educa-
tion level, are trained in their use, and supported to fol-
low up children; (3) fears were expressed that CMDs
who collect blood using RDTs could expose the children
to HIV, that the tests could be used to test children for
HIV, or that the blood could be used for witchcraft; (4)
CMDs were anticipated to face challenges with transport
for follow up of patients and re-stocking of supplies,
Table 1 Number and mix of key informants and focus groups conducted
Key Informant Interviews (KIIs) Number Focus Group Discussions (FGDs) Number
Health workers at local Health centre III 2 Female caregivers/mothers of children under five years 4
Civil society leaders/teachers 2 Male caregivers/fathers of children under five years 4
Local political leaders 2 Community medicine distributors (CMDs) 2
Health unit management committee members 2
Religious leaders 2
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their children be treated instead of being referred.
Trust in and acceptability of CMDs managing children
with fever
T h er o l eo fC M D si nm a l a r i am a n a g e m e n tw a sw e l l
appreciated by the community since the CMDs were
perceived to be accessible both physically and socially.
Many community members reported trust and confi-
dence in CMDs ability to handle sick children given
their past experiences of helpful available CMDs.
“S h e[ t h eC M D ]e v e na s k su st ot a k eo u rc h i l d r e n
when they are sick to give us drugs. She has been
very good because even if I go to her place at night
she opens and gives me drugs. Even if I find her in
the garden digging she comes back home to give me
medicine. I trust her.” (FGD, female caregivers)
T h es p i r i to fv o l u n t e e r i s ma sd e m o n s t r a t e db yC M D s
not demanding to be paid for their services was greatly
appreciated by community members, and their trust and
confidence in the CMD services was often the main
motivating factor for the CMDs to do voluntary work.
The community members who had used the CMDs per-
ceived the medicines provided to them as effective in
treating children with malaria, and the recovery of sick
children after treatment by CMDs was said to enhance
the reputation of the CMDs amongst their neighbours
and community.
“According to me, they [CMDs] have done commend-
able work. They have a good relationship with the
people and they have helped them a lot. They have
been effective in distributing Homapak® and Coar-
tem®. I heard that the tablets are to be distributed
freely and they are doing it - they fulfilled the inten-
tion. My twins are making 3 years and I’ve never
taken them to hospital. They are treated at home
and given Coartem®. They [CMDs] have never asked
for money for treatment.” (KI, community leader)
Health workers reported to have observed a reduced
workload at the health facilities as a result of CMD
management of children with fever in the communities.
“We have trained CMDs in many workshops. We
taught them about the danger signs, so in case of
such they refer them to the health centre immedi-
ately. The CMDs also sensitize the communities
where they stay on malaria prevention. They have
really helped us health workers. The work load has
reduced. We appreciate [their contribution]”. (KI,
health worker)
“There is a good relationship with us because they
know where they stop. They know that they can’t
manage [everything] according to how they were
trained. [For complicated cases] they immediately
refer them to the health facilities. These people have
really helped very much in the areas where they
operate. We have not heard cases that a child has
died at the CMDs level.” (KI, health worker)
H o w e v e r ,t h e r ew e r ea l s os o m er e s e r v a t i o n sa b o u t
CMDs performance in the management of malaria at
community level. Some informants reported that CMDs
are sometimes difficult to find and in some instances
they are looked down upon by caregivers because they
are not trained professionals. Others reported that medi-
cine distribution is a difficult task and that CMDs can
easily give medicines without understanding what the
underlying problem is. Some KIs indicated that CMDs
are not trusted because of their low level of education.
“In some cases [instances] they are minimized
because they are not trained professionals. Medicine
distribution [prescription] is very hard and they can
easily give you medicine without understanding what
you are suffering from. If you explain to him that you
h a v em a l a r i ao rt h a ty o ua r en o tf e e l i n gw e l l ,o f
cause; for him he has the medicine he just gives you”.
(FGD, male caregivers)
Opinions, concerns and acceptability of the use of RDTs
by CMDs
Although it emerged that community members had some
doubts about CMD skills, there was consistency across
t h eF G D sa n dK I I sah i g hd e g r e eo fc o n f i d e n c et h a t
CMDs can perform the test once they are provided with
adequate training. This trust and confidence was based
on the education level of the CMDs, their experience, as
well as perceptions about their commitment to work.
“If a person is trustworthy in a small thing they can
work equally well even in a bigger one. These people
have worked well and we never got problems with
them. If my child falls sick, I just cross the road to
him instead of going to Namungalwe where a person
from Marina [name of place outside Iganga] knows
nothing about me.” (FGD, male caregivers)
Community members also echoed the need for
refresher training for CMDs in addition to training on
RDTs.
“That will be very good [introducing RDTs] only that
they will need to be trained like how they were
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health worker)
“I would second it [introducing RDTs] provided they
are trained to do it safely. It is very important.” (KI,
community leader)
CMDs expressed willingness to use RDTs as part of
the services they provide, and are confident they can
perform it if they receive adequate training. CMDs con-
tended that they have been voluntarily distributing
drugs and would now volunteer also for this new task.
CMDs were optimistic that the community would wel-
come their use of RDTs.
“If they know that we have been trained, they will
a c c e p t[ t h eu s eo fR D T s ] .E v e nf o rt h eg i v i n go u t
drugs they first resisted but later accepted.” (FGD,
CMDs)
Also the majority of health workers supported the idea
of CMDs conducting RDTs as long as they are given
practical training to acquire additional skills, accurate
information, and guidelines to ensure safety. They
asserted that this is one way of taking services nearer to
people, encourage early treatment seeking behaviour,
and is one way of providing CMDs with additional skills
crucial for managing malaria. They also appreciated the
fact that the CMD treatment of malaria could be per-
formed more effectively if an RDT was introduced, so as
to distinguish between malaria and other types of fever.
“That is a good thing [the use of RDTs], and it will
w o r kb e c a u s ep e o p l eh a v eb e e nc o m i n gh e r eal o t
because of malaria. So if it [RDT and malaria treat-
ment] is taken near them it will help them so that a
person knows what is required and will help them
get early treatment. But these CMDs need to be given
additional skills because they need to have enough
information to avoid questions like why they are tak-
ing blood.” (KI, health worker)
Fears and stigma associated with taking blood from
children in the community
Even though most community members were positive
towards the use of RDTs by CMDs, many had mixed
feelings about the taking of blood from children. The
fear included concerns that their children could get
infected with HIV in the process of undertaking an
RDT and that the blood could be used to test children
for HIV rather than malaria.
“People have fears about blood and that it can lead
to contracting HIV. It would also imply to some
people that when they prick to test the blood, they
think you are testing for HIV but not malaria. They
believe you can prove malaria by mere looking at
signs like vomiting, shivering, diarrhea and other
basic signs.” (KI, community leader)
Another frequently mentioned concern was that the
blood could end up in the wrong hands and be used for
witchcraft.
“Since people use it [blood] for bewitching, someone
can draw it from you without you being aware that
it will be used for other things. If you have a co-wife
she can use it to bewitch you to death or stop produ-
cing children. Some say that they use it as sacrifice.”
(FGD, female caregivers)
Challenges anticipated to hamper the success of CMD
management of fever using RDTs
Given the tasks that the CMDs are given, views regard-
ing the challenges that CMDs are likely to face were
solicited. The reported challenges that were foreseen
included that CMDs will lack transport for follow up of
patients and for replenishment of supplies from the
health facilities, that adults will try to force CMDs to
also test them for malaria, that caregivers will insist that
CMDs treat their children even when the child needs
referral, and that some leaders will try to seek for
favours for themselves and their relatives.
“I have seen some of them [CMDs] walking all the
way to the health center to get drugs, and when fol-
lowing up children. They need to be assisted with
transport for drugs”. (FGD, male caregivers)
“These tests [RDTs] will create a lot of interest. I am
concerned that adults will also demand to be tested.
It h i n ka l s os o m eo fo u rp e o p l ew i l li n s i s tt h a tt h e i r
children are treated when they should be referred as
now CMDs will be seen as “little doctors” who can
take blood and examine it”. (KI, community leader)
Discussion
The study found that community medicine distributors
(CMDs) were trusted by their communities because of
their voluntary services, ease of access, and perceived
effectiveness of the anti-malarial drugs they use. This is
in line with the findings from a multi-country study
(including Uganda) which showed high community
acceptability of CMD management of sick children, with
most children receiving treatment on the same day or
within one day of onset of symptoms [39]. Kilian et al
[13] found similar results in western Uganda, where
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malarial drugs in the hands of CMDs. However, while
Ajayi et al [39] also concluded that most caregivers per-
ceived the anti-malarials used by CMDs to be effective,
Nsabagasani et al [40] demonstrated that although care-
givers concurred that theyw e r eb e n e f i t i n gf r o mt h e
CMD programme, the treatment was perceived as a
drug of lower quality. The contradicting finding is likely
to be a result of the type of medicine used, as Ajayi
et al [39] evaluated the use of highly efficacious pre-
packed ACT, whereas Nsabagasani et al [40] evaluated
the use of Homapak® (chloroquine and sulphadoxine/
pyrimethamine) - a combination drug known to have
low clinical efficacy due to parasite resistance.
CMDs were trusted by health workers who recognized
that the CMDs have contributed to a reduced workload
in the health facilities. This concurs with what was
found in a rural district in Burkina Faso, where a reduc-
tion in workload at peripheral health facilities was
observed after HMM was implemented [41]. Similarly,
HMM with ACT using community health workers who
are supervised regularly was found to be feasible and
acceptable by health workers in Ghana [42]. In resource
constrained rural communities with geographically
sparse health services, CMDs could fill a major gap in
access to health care for under-five children [43]. The
high level of community acceptability for HMM is likely
a result of its convenience, given the fact that malaria
risk is often highest in remote rural areas where the
quality and coverage of health services is lowest [44].
In this study, the formal education level of CMDs
appeared to be a key factor in their acceptability by the
community, with CMDs with low education being
viewed less positively. This finding needs to be explored
further, as it could have major implications on what cri-
teria should be used to select CMDs under home man-
agement of malaria (HMM) programmes. Current
selection criteria for the community to consider when
they choose their CMDs include: age, literacy levels, and
gender but different districts and sub-districts may how-
ever, choose different criteria for nominating CMDs and
ability to read and write may not be prioritized in cer-
tain areas [45]. If shown to be consistent across coun-
tries and programmes, this could have negative
implications if RDTs are to be deployed. Alternatively,
programs that want to scale up CMD use of RDTs
would need to demonstrate that CMDs are able to use
the test and that communities accept their services,
regardless of education level.
A majority of community members, health workers
and CMDs welcomed the use of RDTs by CMDs, pro-
vided that they are properly trained in their use. A simi-
lar study in Sudan also found community acceptability
of Coartem® and RDTs in HMM to be high, with a
marked increase in treatment-seeking behaviour follow-
ing the implementation [46]. In the present study, the
high community acceptability of RDTs was partly due to
the appreciation that CMDs would be able to offer
treatment which was based on test results rather than
just presence of symptoms and signs.
While RDTs have the potential to greatly enhance the
management of febrile illness [47] the success of their
u s ei nt h eh a n d so fC M D si sh i g h l yd e p e n d e n to nh o w
the community will accept the services provided. Health
care policies such as HMM are often formulated at
national level and need to take into account local cultural
context; sometimes assumptions are made based on what
can be communicated through simplified biomedical
terms, and how this will result in behaviour change [48].
However, acceptability of medical care by different ethnic
groups is associated with the degree to which the services
meet cultural values, norms, and expectations [49]. These
factors need to be taken into account to ensure successful
uptake of community programs [50]. While a desirable,
participatory process in every village is not compatible
with rapid national scale-up - a balance needs to be
reached [40]. Having CMDs of the same ethnic group,
who speak the same language, and are familiar with the
culture and its traditions and values are factors that can
increase acceptability [51]. The findings of this study also
show that the community demands for well trained
CMDs to handle and interpret the tests - some critical
characteristics also identified by Din and Bell [52].
Equally, programmes will need to address concerns about
children with false negative results, as now CMDs will be
required to without the ACT. If, however, the child is not
followed closely and gets worse or even dies, this could
potentially undermine the credibility of the entire pro-
gramme. In the trial that followed this study, blood slides
for microscopy were collected from each child on the
same day; microscopy results for all RDT negative chil-
dren were returned to the CMD within 24 hours to try
and address this problem. This approach will not be pos-
sible in non-research settings.
Fears and stigma of taking blood of children in the
community were common, relating both to risk of expo-
sure to HIV and witchcraft. Myths about blood could
have serious consequences to the HMM programme,
especially if there is a bad outcome for a child. In Tan-
zania, though there was a high degree of provider and
caregiver acceptance and satisfaction with RDTs, some
caregivers had reservations about RDTs, with some
thinking they were HIV test kits [30]. To counter for
this potential threat to the programme, a well-designed
behaviour change communication strategy will be
required, since a successful HMM strategy relies not
only on adequately trained CMDs and the availability of
drugs, but also on a well informed community [53,43].
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CMDs would face difficulties with adults demanding to
be tested and caregivers insisting that their children
should be treated instead of being referred. Compliance
to guidelines is often a major challenge and a study in
Burkina Faso found very low health worker compliance
to negative RDT results, as they still went on to pre-
scribe anti-malarial drugs for patients who tested nega-
tive [54]. This was also observed in another study in
Sudan [46]. These issues will require special attention
through frequent supportive supervision meetings to
monitor and assess performance, and during regular
CMD mentoring sessions. It has been observed that
lower level health workers are more likely to comply
with guidelines as compared to more experienced or
high cadre health workers [55]. A follow up study is
planned to assess community acceptability of RDT use
by CMDs following RDT deployment in HMM.
Methodological considerations
One of the limitations of qualitative methods is that the
magnitude of a variable of interest across different cate-
gories of respondents cannot be measured. However, it
was not the intent of this study to quantify the issues
under study as a household survey is planned for this
purpose. Triangulation of information from caregivers,
health providers, CMDs and community and opinion
leaders using both FGDs and KIIs, was a useful strategy
for checking consistency and contradictions across and
within groups [56,57]. The geographical spread of the
FGDs allowed us to interview participants from across
the study area, getting as close to representative views
of the study population as practically possible. Separat-
ing women from men in the FGDs and focused ques-
tions to the research issues could have promoted free
expression of the participants and also reduced answers
given to please the researcher.
Conclusion
Use of rapid diagnostic tests (RDTs) by community
medicine distributors (CMDs) is likely to be acceptable
by community members given that CMDs are properly
trained, supported and provided logistical support. A
well-designed behaviour change communication strategy
is needed to address the anticipated programmatic chal-
lenges as well as community fears and stigma about
drawing blood. Level of formal education may have to
be a criterion for CHW selection into programmes
deploying RDTs.
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